Hannah Dzimitrowicz McManus (@hannahdzmd) 's Twitter Profile
Hannah Dzimitrowicz McManus

@hannahdzmd

Genitourinary medical oncologist @DukeGUCancer

ID: 1044763603222581249

calendar_today26-09-2018 01:40:28

83 Tweet

446 Takipçi

424 Takip Edilen

Chenyu Lin, MD (@chenyulinmd) 's Twitter Profile Photo

Cord expansion w/ #omidubicel shows long-term graft durability and safety in our pooled analysis of 5 multicenter clinical trials, now out in Transplantation and Cellular Therapy Journal. Thanks to mentor Mitch Horwitz Duke Hematologic Malignancies & Cellular Therapy, participating sites, & patients 🙏 #bmtsm Hem-Onc Fellows Network astctjournal.org/article/S2666-…

Kidney Cancer (@kidneycancer) 's Twitter Profile Photo

KCA Medical steering committee member Tian Zhang, MD, MHS calling on the #kidneycancer community to rise to the challenge of treating refractory RCC. Second line strategies depend on first line but also timing of resistance and progression. #GU23

KCA Medical steering committee member <a href="/TiansterZhang/">Tian Zhang, MD, MHS</a> calling on the #kidneycancer community to rise to the challenge of treating refractory RCC. Second line strategies depend on first line but also timing of resistance and progression. #GU23
Hannah Dzimitrowicz McManus (@hannahdzmd) 's Twitter Profile Photo

Always a pleasure chatting with Andrew Armstrong about how to improve care for our patients with #prostatecancer ! Check out this new podcast series discussing mHSPC.

Hannah Dzimitrowicz McManus (@hannahdzmd) 's Twitter Profile Photo

Tune in and bring your questions tonight! Very excited to chat all things parp/arpi and #prostatecancer with Andrew Armstrong Great way to start the week leading up to #GU24 ASCO ! #bestweekever

Matt Labriola (@mattlabsmd) 's Twitter Profile Photo

Awesome start to #GU24 sharing our clinical and implementation outcomes using pluvicto at DCI Center for Prostate & Urologic Cancers with rising ⭐️s Valeria Maldonado Grijalva and Marybeth Nedrud, connecting with forever mentor/friend Tian Zhang, MD, MHS, and team bonding thanks to the GOAT Dan George

Awesome start to #GU24 sharing our clinical and implementation outcomes using pluvicto at <a href="/DukeGUCancer/">DCI Center for Prostate & Urologic Cancers</a> with rising ⭐️s Valeria Maldonado Grijalva and Marybeth Nedrud, connecting with forever mentor/friend <a href="/TiansterZhang/">Tian Zhang, MD, MHS</a>, and team bonding thanks to the GOAT <a href="/Daniel_J_George/">Dan George</a>
Andrew Armstrong (@aarmstrongduke) 's Twitter Profile Photo

Wondering what to offer your NEPC/small cell prostate cancer patient after platinum chemo? Clinical trials but also perhaps lurbinectedin! See DCI Center for Prostate & Urologic Cancers poster with Alan H Bryce showing activity. #GU2024

Wondering what to offer your NEPC/small cell prostate cancer patient after platinum chemo? Clinical trials but also perhaps lurbinectedin! See <a href="/DukeGUCancer/">DCI Center for Prostate & Urologic Cancers</a> poster with <a href="/AlanBryce9/">Alan H Bryce</a> showing activity. #GU2024
#TumorBoardTuesday (@tumorboardtues) 's Twitter Profile Photo

1/4 🚨 Time for a #TumorBoardTuesday extra! Andrew Armstrong discusses developments w PARPi from #GU24: - Sequence PARPi, vs w ARSI upfront? - Which mutations benefit most from PARPi? - Role for PARPi in castration sensitive #prostatecancer? Keep scrolling for 📽️ updates👇

1/4 🚨 Time for a #TumorBoardTuesday extra! <a href="/AarmstrongDuke/">Andrew Armstrong</a> discusses developments w PARPi from #GU24:

- Sequence PARPi, vs w ARSI upfront? 
- Which mutations benefit most from PARPi?
- Role for PARPi in castration sensitive #prostatecancer? 

Keep scrolling for 📽️ updates👇
Hannah Dzimitrowicz McManus (@hannahdzmd) 's Twitter Profile Photo

At #AACR2024 ? Come check out our poster examining uptake of guideline concordant mHSPC care in IRONMAN Registry . Rapid uptake of changing therapies and 86% rate overall📈. Important to develop quality benchmarks to ensure #prostatecancer patients getting best therapies.

At #AACR2024 ? Come check out our poster examining uptake of guideline concordant mHSPC care in <a href="/IRONMANregistry/">IRONMAN Registry</a> . Rapid uptake of changing therapies and 86% rate overall📈. Important to develop quality benchmarks to ensure #prostatecancer patients getting best therapies.
Tian Zhang, MD, MHS (@tiansterzhang) 's Twitter Profile Photo

The #WomeninOncology networking center has a wonderful line up at #ASCO24! Privileged to join Katherine Van Loon, MD, MPH Suzanne Cole, MD #JeannyArahonChing #TriciaKalwar on Combating the Saboteurs panel Join: 6/1 3:15-4pm in S502 & for all the programming & connections! conferences.asco.org/am/womens-netw…

The #WomeninOncology networking center has a wonderful line up at #ASCO24!

Privileged to join <a href="/KVanLoonMD/">Katherine Van Loon, MD, MPH</a> <a href="/SuzanneColeMD/">Suzanne Cole, MD</a> #JeannyArahonChing #TriciaKalwar on Combating the Saboteurs panel

Join: 6/1 3:15-4pm in S502
&amp; for all the programming &amp; connections!
conferences.asco.org/am/womens-netw…
Dan George (@daniel_j_george) 's Twitter Profile Photo

Large UK Biobank study confirmed many heritable gene-cancer associations. Shevach and Hannah Dzimitrowicz McManus explain how the new data underlines that ppl w many cancers types & THEIR FAMILIES should get genetic screening & that we must stop disparities in testing. Duke Cancer Kathleen Cooney

Hannah Dzimitrowicz McManus (@hannahdzmd) 's Twitter Profile Photo

Thank you World GU Conference for the opportunity to share our work in IRONMAN Registry demonstrating the ability to adapt guideline concordant care for #prostatecancer in the real world. Fantastic conference for learning, networking, and fun! IDEOlogy Health